Literature DB >> 31207068

Phylogeography, phylodynamics and the recent outbreak of lineage 3 porcine reproductive and respiratory syndrome viruses in China.

Yan-Kuo Sun1,2, Xiao-Liang Han1,2, Ying-Fang Wei1,2, Zhi-Qing Yu1,2, Chi-Hai Ji1,2, Qi Li1,2, Gang Lu1,2, Liang Shen3, Chun-Quan Ma4, Heng Wang1,2, Gui-Hong Zhang1,2.   

Abstract

Novel highly pathogenic porcine reproductive and respiratory syndrome viruses (PRRSVs) have attracted increasing attention owing to their continual high emergence and recent re-emergence. Recently, lineage 3 PRRSVs, belonging to the type 2 viruses, with novel characteristics and increased virulence have been continuously re-emerging in China, thereby posing a great threat to pig farming. However, available information about lineage 3 is limited. Here, we carried out molecular epidemiological investigations for PRRSV surveillance in most regions of China from 2007 to 2017. More than 3,000 samples were obtained, amounting to 73 sequences of lineage 3 viruses. The origin, demographic history and spread pattern of lineage 3 PRRSVs were investigated combining with the database globally. Phylogeography and phylodynamic analyses within a Bayesian statistical framework revealed that lineage 3 viruses originated in Taiwan. Followed by subsequent propagation to different areas and geography, it dichotomized into two endemic clusters. South China has become an epicentre for these viruses, which diffused into China's interiors in recent years. Furthermore, viral dispersal route analysis revealed the risk of viral diffusion. Overall, the origin, epidemic history and geographical evolution of lineage 3 PRRSVs were comprehensively analysed in this study. In particular, the epicentre of southern China and the diffusion routines of the viruses are highlighted in this study, and the possible continuous transmission of the novel lineages poses the biggest threat to pig farmers.
© 2019 Blackwell Verlag GmbH.

Entities:  

Keywords:  China; lineage 3; phylodynamics; phylogeography; porcine reproductive and respiratory syndrome virus; type 2

Mesh:

Year:  2019        PMID: 31207068     DOI: 10.1111/tbed.13269

Source DB:  PubMed          Journal:  Transbound Emerg Dis        ISSN: 1865-1674            Impact factor:   5.005


  7 in total

1.  Genome-Wide Characterization of QYYZ-Like PRRSV During 2018-2021.

Authors:  Hu Xu; Lirun Xiang; Yan-Dong Tang; Chao Li; Jing Zhao; Bangjun Gong; Qi Sun; Chaoliang Leng; Jinmei Peng; Qian Wang; Guohui Zhou; Tongqing An; Xuehui Cai; Zhi-Jun Tian; Hongliang Zhang; Mingxin Song
Journal:  Front Vet Sci       Date:  2022-06-30

2.  The Diversity and Spatiotemporally Evolutionary Dynamic of Atypical Porcine Pestivirus in China.

Authors:  Hailong Ma; Wentao Li; Mengjia Zhang; Zhengxin Yang; Lili Lin; Ahmed H Ghonaim; Qigai He
Journal:  Front Microbiol       Date:  2022-06-24       Impact factor: 6.064

3.  Evolutionary Dynamics of Type 2 Porcine Reproductive and Respiratory Syndrome Virus by Whole-Genome Analysis.

Authors:  Jiahui Guo; Zimin Liu; Xue Tong; Zixin Wang; Shangen Xu; Qian Chen; Junwei Zhou; Liurong Fang; Dang Wang; Shaobo Xiao
Journal:  Viruses       Date:  2021-12-09       Impact factor: 5.048

4.  Comprehensive phylogeographic and phylodynamic analyses of global Senecavirus A.

Authors:  Han Gao; Yong-Jie Chen; Xiu-Qiong Xu; Zhi-Ying Xu; Si-Jia Xu; Jia-Bao Xing; Jing Liu; Yun-Feng Zha; Yan-Kuo Sun; Gui-Hong Zhang
Journal:  Front Microbiol       Date:  2022-09-29       Impact factor: 6.064

5.  Antiviral Effects of Heparan Sulfate Analogue-Modified Two-Dimensional MXene Nanocomposites on PRRSV and SARS-CoV-2.

Authors:  Ting Tong; Wantao Tang; Shaobo Xiao; Jiangong Liang
Journal:  Adv Nanobiomed Res       Date:  2022-08-15

6.  Evaluation of a type 2 modified live porcine reproductive and respiratory syndrome vaccine against heterologous challenge of a lineage 3 highly virulent isolate in pigs.

Authors:  Fu-Hsiang Hou; Wei-Cheng Lee; Jiunn-Wang Liao; Maw-Sheng Chien; Chih-Jung Kuo; Han-Ping Chung; Min-Yuan Chia
Journal:  PeerJ       Date:  2020-03-30       Impact factor: 2.984

7.  Efficacy Evaluation of Two Commercial Vaccines Against a Recombinant PRRSV2 Strain ZJnb16-2 From Lineage 8 and 3 in China.

Authors:  Guangwei Han; Huiling Xu; Yanli Wang; Zehui Liu; Fang He
Journal:  Pathogens       Date:  2020-01-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.